Sort   by:  
 Page size 
UnknownPhase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
Not available
S-EPMC4021043 | biostudies-literature
UnknownAn expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.
Not available
S-EPMC10410686 | biostudies-literature
UnknownTwo cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.
Not available
S-EPMC4482861 | biostudies-literature
UnknownGlioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.
Not available
S-EPMC6785354 | biostudies-literature
UnknownSeven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
Not available
S-EPMC7483960 | biostudies-literature
Sort   by:  
 Page size